Fellowship Training Opportunities In Transplant Infectious Diseases

Below is a list of fellowship training opportunities for transplant infectious diseases. If you would like to post a clinical or research position for physicians-in-training, please send a brief (200-word limit) announcement to the IDCOP staff liaison, Victoria Marino, at vmarino@myast.org. The announcement should include the contact information (address, phone, fax, and/or e-mail) of the recruiter.

• Ajmera Transplant Centre, University Health Network, University of Toronto, Canada
• Cleveland Clinic
• David Geffen School of Medicine at UCLA
• Duke University School of Medicine
• Henry Ford Health System
• Houston Methodist Transplant and Oncology Infectious Diseases Fellowship
• Johns Hopkins University
• Keck Medicine of USC
• Massachusetts General Hospital
• Mayo Clinic
• Medical University of South Carolina
• Moffitt Cancer Center
• NIH/NIAID (in conjunction with Johns Hopkins University)
• Nationwide Children's Hospital/Ohio State University
• Stanford University
• University of Alabama at Birmingham Immunocompromised/Transplant ID Fellowship
• University of Alberta
• University of Miami Miller School of Medicine
• University of Minnesota
• University of North Carolina
• University of Pittsburgh Medical Center
• University of Texas at Houston McGovern Medical School
• University of Texas MD Anderson Cancer Center
• UT Southwestern Medical Center
• Vanderbilt University Medical Center (VUMC)

Additional Opportunities:

• Emory University
• Icahn School of Medicine at Mount Sinai
• Ochsner Medical Center

---

AMJERA TRANSPLANT PROGRAM, UNIVERSITY HEALTH NETWORK, UNIVERSITY OF TORONTO, CANADA ^{(Updated September 2022)}

The Amjera Transplant Program (Amjera), University Health Network, and University of Toronto offer a world-class experience for graduating fellows seeking to develop, or continue developing, an academic career in transplant infectious diseases. We offer a combined clinical/research fellowship that is one or two years in duration.

Amjera is one of the largest transplant programs in North America (both solid organ and stem cell) and is a world-leader in clinical, educational, and research aspects of transplantation. The Transplant Infectious Diseases Training Program is based on the curriculum suggested by the AST Infectious Diseases Community of Practice and is further enhanced under the leadership and guidance of internationally recognized transplant infectious diseases experts: Drs. Sasan Hosseini, Atul Humar, Shahid Husain, Deepali Kumar, Coleman Rotstein, and Asma Syed. Currently, we offer two training tracks for fellows entering our program: a one-year clinical track for fellows interested in a career as a clinician-educator and a two-year track for fellows interested in an academic research career.

For inpatient consultation, fellows rotate through two sites, one that specializes in solid organ transplant (Toronto General Hospital) and the other in allo- and auto-stem cell transplant/leukemia/solid tumour (Princess Margaret Cancer Centre). For a comprehensive outpatient experience, fellows have a once-weekly outpatient clinic throughout the fellowship. Fellows can also choose to do electives in primary solid-organ transplant rotations, which enriches the transplant experience. In addition, we provide a well-structured weekly, interactive lecture series where invited speakers, core faculty, and fellows review core and advanced topics in transplant infectious diseases. Fellows are also encouraged to attend local, national and international transplant conferences.

Fellows interested in the research track are encouraged to participate actively in the research endeavors of our faculty, and begin their own projects. We pay special attention to developing, clinical, translational, and laboratory research skills through well-funded clinical and lab-based research programs in transplant infectious diseases. Our previous fellows have been successful in their research endeavors and have presented and published widely.

Interested applicants are advised to submit their updated CV, statement of interest, and three letters of recommendation by July 31 to: Sasan Hosseini, MD, MSc, MPH, Fellowship Director, Transplant-Oncology Infectious Diseases, at sasan.hosseini@uhn.ca.

Back to Top

CLEVELAND CLINIC ^{(Updated August 2018)}

The Cleveland Clinic Department of Infectious Disease (Adult) is offering a funded, one-year Transplant ID Special Fellowship which runs from July through June of the following year. This position is open to physicians who will have completed at least 2 years of ID fellowship by the start date of the program. This fellowship will combine strong clinical training in all organs (lung, liver, intestinal, pancreas, kidney, heart) and HSCT and leukemia patients with clinical research projects. The Cleveland Clinic is a high-volume, high-quality transplant center. Cleveland Clinic ID faculty have a strong focus on teaching. Members of the faculty collaborate with the AST ID Community of Practice; including co-authors of AST ID Guidelines, and co-authors of guidelines for IDSA and ISHLT.

In addition to the year-long Transplant ID Special Fellowship, the Cleveland Clinic Department of Infectious Disease offers a 4-week elective in adult Transplant ID for visiting ID fellows. Participants should be ID fellows in good standing in accredited programs and can elect all 4 weeks or 2 weeks/ 2 weeks from among the solid organ transplant ID service and the HSCT/leukemia/oncology ID service. Formal didactic sessions are combined with opportunities to evaluate and manage a wide variety of transplant inpatients with infection-related issues. Candidates for the year-long Cleveland Clinic Transplant ID Special Fellowship are encouraged, though not required, to schedule this elective in advance of submitting their application.

For more information, please contact Mrs. Teresa Hahn, Program Coordinator, at hahnt3@ccf.org.

Please send inquiries to:

Eric Cober, MD
Program Director
Transplant Infectious Disease Fellowship Program
Cleveland Clinic Foundation
9500 Euclid Avenue, G21
Cleveland, OH 44195
Telephone: (216) 636-1873
Fax: (216) 445-9446
E-mail: cobere@ccf.org

Back to Top

DAVID GEFFEN SCHOOL OF MEDICINE AT UCLA ^{(Updated July 2023)}

The Division of Infectious Diseases at the David Geffen School of Medicine at UCLA is offering a one-year clinical fellowship and advanced training program in Transplant Infectious Diseases. Eligible applicants will have completed at least two years of an ACGME-accredited ID fellowship program and be either board certified or board eligible in infectious disease.

The focus of this position is to provide advanced training in Transplant Infectious Diseases and will offer exposure to patients undergoing heart, lung, liver, and kidney transplantation and ventricular assist device implantation, as well as patients with hematologic malignancies and undergoing hematopoietic cell transplantation. UCLA Medical Center has one of the highest volume solid organ transplantation programs in the country, with over 600 transplants annually including >100 thoracic organ transplants.

Our Transplant ID fellowship includes inpatient clinical rotations, in combination with outpatient clinical care of pre- and post-transplant patients. Transplant ID fellows will have the opportunity to perform a mentored research project on a relevant topic, including infection control, invasive fungal infections, and challenges faced by the older transplant patient. Applicants submit a one-page personal statement, cover letter, and 3 letters of recommendation. Applications are accepted on a rolling basis.

We are currently accepting applications for the 2025-2026 academic year through September 1, 2024, with application review on a rolling basis. We also remain open to applicants who wish to start during the 2024-25 academic year.  Please feel free to reach out to our program with any questions.

Joanna Schaenman
Email: jschaenman@mednet.ucla.edu
https://recruit.apo.ucla.edu/JPF08505

Back to Top

DUKE UNIVERSITY SCHOOL OF MEDICINE (Updated April 2021)

Duke University Medical Center is a high-volume solid organ and stem cell transplant center with an active Transplant/Immunocompromised Host Infectious Disease (TxID) Service staffed by eleven core faculty committed to training ID fellows to be leaders in the care of immunocompromised hosts. ACGME-accredited training programs in both ID and Medical Microbiology, state-of-the-art research training under the mentorship of 26 highly successful basic science, translational, and clinical investigators across 6 departments and NIH funding for training in TxID (T23 AI100851-01) provide the infrastructure for unparalleled TxID training at Duke.

There are two options for TxID training. Trainees will provide both inpatient and outpatient consultative support for a growing population of solid organ transplant recipients of all organ types, as well as hematopoietic stem cell transplant recipients and patients with hematologic malignancy. The first option is one year of training for trainees who have completed two years of an accredited ID fellowship program and includes six months of clinical care on the TxID consult service and six months of research. The second option is a three-year training program on an NIAID-sponsored T32 Transplant ID Training Grant, the purpose of which is to train physician-scientists. This program is available to trainees who have completed one year of clinical ID training and includes six months of clinical care on the TxID consult service and 30 months of either basic or clinical research. Formal instruction addresses scientific writing, research design, statistical analysis, ethical/regulatory issues, and the art and science of transplantation medicine. Advanced degree options (e.g., Masters in Health Science) are available.

Applicants will have earned an MD and completed ACGME-accredited Internal Medicine Residency and Infectious Diseases Fellowship Programs (or equivalent). Those interested in the three-year training option must be a U.S. citizen (eligible for NIH funds). Fellows are selected solely on the basis of qualifications and independent of race, sex, or national origin. International Medical Graduates (IMG) should note that completion of an ACGME-accredited (or equivalent) Internal Medicine Residency Training Program and ABIM board-eligibility in Internal Medicine is required for ABIM board-eligibility and certification in Infectious Diseases. Our program accepts applications sponsored on J1 clinical visas from ECFMG provided above eligibility requirements for training are met. 

Program completion confers ID board eligibility. All fellows who have elected advanced training in TxID at Duke hold academic appointments are involved in the care of immunocompromised hosts, and ~80% are active physician-scientists.

Interested applicants are asked to send their curriculum vitae (CV), statement of interest, and at least three letters of recommendation (including from most recent training program director) by June 1 prior to the year of the fellowship start date to:

Eileen K. Maziarz, M.D.
Assistant Professor of Medicine
Division of Infectious Diseases
Program Director, ID Fellowship
Duke University School of Medicine 
eileen.maziarz@duke.edu 

Barbara D. Alexander, MD, MHS 
Director, Transplant Infectious Disease (ID) Service
Director, Transplant ID Fellowship Program
Head, Clinical Mycology Laboratory
Professor of Medicine and Pathology
Duke University School of Medicine
barbara.alexander@duke.edu

Back to Top

HOUSTON METHODIST TRANSPLANT AND ONCOLOGY INFECTIOUS DISEASES FELLOWSHIP  ^{(Added October 2023)}

Houston Methodist Hospital (HMH) offers a year-long funded Oncology-Transplant Infectious Diseases Advanced Fellowship in collaboration with MD Anderson Cancer Center, with options for an additional research year. HMH conducted more than 10,000 SOT since 1963, and more than 600 SOT in 2022 (7th in the nation), including heart (15th), lung (12th), kidney &/or pancreas (27th), liver transplant (2nd), and multi-organ (1st). Transplant ID fellow will rotate six months at HMH and five months at MD Anderson Cancer Center (two months for Stem Cell Service, two months for Leukemia, and one month for Medical Oncology). Through a combination of comprehensive training, hands-on experience, and exposure to cutting-edge facilities, you will emerge as a proficient clinician capable of addressing complex cases in immunocompromised patients with cancer, Hematopoietic Stem Cell Transplantation (HSCT), and Solid Organ Transplantation (SOT). 

Eligibility and Application: 

• Previous Completion: Successful graduation from an ACGME-accredited 2-year General Infectious Disease Fellowship Program before the Transplant and Oncology ID fellowship's start date.
• Letters of Recommendation: Submit three letters of recommendation, including at least one from the program director of your General Infectious Disease Fellowship.
• Updated CV: Provide an updated Curriculum Vitae highlighting your academic achievements, clinical experiences, and research contributions.
• Statement of Interest: Submit a personal statement detailing your interest in the program and your aspirations within the field of transplant-oncology related infectious diseases.

Please send inquiries to program coordinator: Michelle Sullins via e-mail at mmsullins@houstonmethodist.org.

Learn more about this exciting opportunity and explore our program on our website: https://www.houstonmethodist.org/education/medical/graduate-medical-education/infectious-disease-fellowship/tracks/.

Adarsh Bhimraj, MD  (Director, Infectious Diseases Fellowship programs ) and Masayuki Nigo, MD, MSc (Associate Program Director, Transplant Infectious Diseases Fellowship)

Back to Top

HENRY FORD HEALTH SYSTEM ^{(Updated August 2023)}

The Division of Infectious Diseases at Henry Ford Health (HFH) is pleased to offer a one-year clinical fellowship in the field of Transplant Infectious Diseases. This training program has been ongoing since 2013. The position requires successful completion of formal fellowship training (minimum 2 years) in an ACGME-accredited Infectious Diseases program. The fellowship will include 7 months of clinical training and 5 months of research. The period of training begins July 1. Remuneration is at the level of a PGY 6 resident. J-1 and H1-B visa are accepted

The training is conducted at the Henry Ford Transplant Institute (HFTI), Henry Ford Cancer Institute (HFCI), and the Karmanos Cancer Institute (KCI). The fellow in Transplant ID receives strong clinical training and provides consultative services in the inpatient and outpatient setting to solid organ transplant (SOT) and hematopoietic stem cell transplant (HCT) patients, high-risk patients with hematological malignancies and cellular therapy, and patients with left ventricular assist devices (LVAD). The training is under the direct guidance of seven core faculty dedicated to the care of transplant and compromised hosts. The fellow will have five months dedicated to conduct individualized mentored projects in the field of transplant infectious diseases, including quality improvement and antimicrobial stewardship in this population.

HFTI is a certified multidisciplinary transplant program recognized for high-quality transplantation services to southeastern Michigan and performs approximately 300 SOTs including liver, kidney, pancreas, heart, lung, intestinal and multivisceral transplants, and implants 60 LVADs each year. HFCI treats approximately 6,000 patients with cancer each year, including HCT and cellular therapy. KCI is an NCI-certified Comprehensive Cancer Center and the largest provider of cancer services in Michigan.

At the end of training, the fellow will understand the unique anatomical, pathophysiological, and immunological factors that contribute to risk of infection, and will be knowledgeable in the management and prevention of infectious complications in this immunocompromised population.

Graduates from our Transplant ID program are presently faculty at academic centers in the US and abroad.

Interested applicants should submit a statement of interest and curriculum vitae to:

George Alangaden, MD
Program Director, Transplant Infectious Diseases, Henry Ford Hospital
Professor of Medicine, Wayne State University
2799 W. Grand Blvd, Detroit MI 48202
Office: 313-916-2573
Fax: 313-916-2993
Email: galanga1@hfhs.org

Back to Top

JOHNS HOPKINS UNIVERSITY ^{(Updated July 2023)}

The Johns Hopkins Comprehensive Transplant and Oncology ID (TOID) Program is accepting applications for rotations of six months or longer duration. Johns Hopkins has a comprehensive, cutting-edge transplant program encompassing a broad range of solid organ and HSCT transplants, including composite tissue allotransplantation, haploidentical HSCT, and HLA/ABO-incompatible kidney transplantation. The Hopkins Transplant ID Faculty, who include Dr. Robin Avery (Program Director), Dr. Shmuel Shoham, Dr. Christine Durand, Dr. M. Veronica Dioverti Prono, Dr. Nitipong Permpalung, Dr. Andrew Karaba, and Dr. Olivia Kates are internationally known for their work in fungal infections, CMV and other viral infections, COVID-19 in transplant and oncology patients, risks and outcomes, and transplantation in HIV and hepatitis infected recipients. Trainees will be exposed to an extraordinary variety of infectious and immunologic issues on a busy inpatient Transplant ID consultation service, with opportunity to participate in outpatient pre-transplant evaluation and continuity clinics. Teaching is a top priority for the Hopkins TOID Faculty, who utilize (and have co-authored) the current AST- and IDSA-approved curriculum for Transplant ID training. There are ample opportunities to do translational and clinical research for motivated fellows who would like to stay in program for a longer duration (up to 2 years). 

The program is considered ACGME- equivalent. Applicants should be current or past fellows in good standing in an ACGME-accredited Infectious Disease Fellowship Program.

In 2021, Johns Hopkins has teamed up with NIH to offer an innovative 1-year combined training fellowship (see detailed description provided below). Applicants are encouraged to apply for either or both of these programs towards specialized TOID clinical and research training. 

For the JHU program, please forward a curriculum vitae and statement of interest to:

Robin K. Avery, MD, FIDSA, FAST
Professor of Medicine, Division of Infectious Disease
Director of Education, Transplant/Oncology ID (TOID)
The Johns Hopkins University
Tel 443-287-4694
Fax 410-614-8518
ravery4@jhmi.edu    and

Darin Ostrander, PhD
Director of Operations, Transplant/Oncology ID Center
Program Manager, TOID Center for Clinical Research
Co-Director, Transplant Research Center
Associate Director of Education, TOID
School of Medicine/Division of Infectious Diseases
The Johns Hopkins University
dostran1@jhmi.edu

Back to Top

KECK MEDICINE OF USC ^{(New December 2022)}

Transplant Infectious Disease Rotation at Keck Medicine of USC

The Division of Infectious Diseases at the Keck School of Medicine of the University of Southern California is offering a 2-week or 4-week clinical rotation on the Transplant/Oncology Infectious Diseases Consult Service to ID fellows currently enrolled in an ACGME-accredited program or senior residents with strong interest in ID. The rotation offers exposure to both oncologic and solid organ transplant patients. The service manages pre-transplant evaluations and post-transplant infectious complications for approximately 500 solid organ transplants each year, including over 200 liver transplants as well as heart, lung, intestine, pancreas, and kidney transplants, and over 250 hematopoietic stem cell transplants per year, including approximately 100 allogeneic transplants, as well as patients undergoing immunosuppressive therapy for advanced and hematologic malignancy. Visiting fellows will also manage outpatients in a dedicated Transplant ID clinic, in addition to attending weekly lectures, case conferences, core lectures, and journal clubs with internal fellows. The rotation is currently offered to internal fellows but is being expanded to external candidates. This option is available to trainees anytime during the academic year, starting in January 2023. Applicants are accepted on a rolling basis.

The host institution will be responsible for malpractice and salary for the trainee during the Transplant Infectious Disease rotation at Keck Medicine of USC. We will provide information/links for housing, recreational options etc., however the costs will need to be covered by the visiting trainee.

Please contact us via email for details regarding application, scheduling, expectations, and logistical support. Contact information: neha.nanda@med.usc.edu  (Interim Chief of Infectious Diseases at Keck School of Medicine) and Saahir.khan@med.usc.edu (Site Director for Transplant ID rotation)

Back to Top

MASSACHUSETTS GENERAL HOSPITAL ^{(Updated September 2020)}

The Transplantation Infectious Disease and Compromised Host Program of the Massachusetts General Hospital (MGH) has trained many leaders in the field of Transplant Infectious Disease in the comprehensive care of immunocompromised individuals. Our faculty and clinical Fellows are integral members of the teams caring for Liver, Kidney, Pancreas, Heart, Lung, VCA and Stem Cell Transplant recipients, individuals with hematopoietic malignancies, and following CAR-T and Immunotherapies.  Fellows are active members of both the Infectious Disease Division of the MGH, and of the MGH Transplant Center and Center for Transplantation Sciences. Applicants will have completed an ACGME-certified clinical Infectious Disease fellowship or the equivalent by the time they start training at MGH. Transplant ID Fellows will participate in both in-patient and out-patient clinical programs. Individualized academic programs are developed for trainees upon acceptance into the program including 4-5 months dedicated to a clinical/basic science research project focused on Transplant Infectious Disease.  Additional research training is available subsequently for interested fellows.

By the end of their training, they will understand:

• Multidisciplinary approaches to complex patients with organ failure, malignancy, and immunosuppression.
• The pre- and post-transplantation assessment of critically ill patients and the timeline of infection after transplantation (See, e.g., Fishman JA, NEJM, 2007, 357, 25:59-72; Fishman JA, Am J Transplant 2017;17:86-879.).
• The optimal deployment of diagnostic techniques in clinical management including radiological and molecular diagnostic tools.
• Development of individualized prophylactic strategies. 
• Important aspects of basic science relevant to transplantation immunology and infectious disease. 
• On-going clinical trials and basic research in transplantation. 

Applicants can send a CV, a brief statement of career goals, and at least two letters of recommendation by September 1 prior to the year of the fellowship start date to:

Jay A. Fishman, M.D.
Director, Transplant Infectious Disease and Compromised Host Program
Associate Director, MGH Transplantation Center
Professor of Medicine, Harvard Medical School
Massachusetts General Hospital Transplantation Center
55 Fruit Street, WH510A
Boston, MA, 02114
(617) 643-4809
fishman.jay@mgh.harvard.edu

Back to Top

MAYO CLINIC ^{(Updated July 2023)}

MAYO CLINIC DIVISION OF INFECTIOUS DISEASES AND THE MAYO TRANSPLANT CENTER in Rochester, Minnesota are offering two positions for one-year fellowship training in Transplant Infectious Diseases. The eligible candidate should be a highly qualified BC/BE infectious diseases physician with an interest in transplantation. The Mayo Transplant Infectious Diseases Fellowship Program offers diverse clinical and research experience in the prevention and management of the infectious complications after solid organ and hematopoietic stem cell transplantation. The training occurs in an environment that promotes teamwork and excellence in clinical practice, research, and education. The trainee, under the direct guidance of an experienced Transplant Infectious Diseases faculty, will participate in a coordinated multidisciplinary approach to patient care. Included in this 12-month fellowship is a 6-month research time to focus on areas of special interest within transplant infectious diseases.

Qualified individuals for this unique opportunity should send a CV and letter of interest to:

Elena Beam, M.D.
Assistant Professor of Medicine, College of Medicine
Focus Group Chair, Transplant Infectious Diseases
Division of Infectious Diseases
Mayo Clinic
200 First Street S.W.
Rochester, MN 55905
Telephone: 507-293-7781
E-mail: beam.elena@mayo.edu

Mayo Foundation is an affirmative action and equal opportunity employer.

Back to Top

MEDICAL UNIVERSITY OF SOUTH CAROLINA (MUSC) ^{(Updated July 2023)}

The Transplant Infectious Diseases program (TID) at the Medical University of South Carolina (MUSC) is now accepting applications for a one-year clinical fellowship in the care of the immunocompromised host. The MUSC TID faculty includes Dr. Courtney Harris (TID Fellowship Director), Dr. Alex Mills, Dr. Ruth Adekunle, Dr. Yosra Alkabab,Dr. Dan Wray, and Dr. John Gnann.

MUSC-Charleston is ranked as the #1 and largest hospital system in South Carolina. Our center provides care for patients with solid organ transplants (heart, lung, liver, kidney, pancreas), LVAD/HVAD, hematopoietic stem cell transplants (SCT), and CAR-T cell recipients. MUSC is the only comprehensive transplant program in South Carolina and therefore provides the prospective TID fellow with exposure to over 750 organ transplants, 150 hematopoietic stem cell transplants, and 50 CAR-T recipients per year.

The program offers 8 months of dedicated clinical time (which includes inpatient TID consults and elective time rounding with sub-specialty teams such as abdominal transplant, SCT, thoracic organ transplant, and antimicrobial stewardship) as well as 4 months of dedicated time for mentored research with the expectation of a published manuscript and/or abstract submission to a nationally recognized meeting prior to graduation. Prospective candidates will also join multidisciplinary selection meetings for both solid organ and stem cell transplants and will have the opportunity for a weekly half-day TID clinic for continuity of care.  Mentorship is a key component of the fellowship, with regular career-planning meetings, guidance about national societies, and education about other types of TID opportunities (protocol development, medical education, etc), with the mission of tailoring each fellowship to the career goals of the fellow.

This position is open to physicians who will have completed an ACGME-certified clinical infectious diseases fellowship or the equivalent by the start date of the program (July 1, 2024). Interested applicants must submit a one-page personal statement of interest, current curriculum vitae, and 2-3 letters of recommendation, including one from the ID fellowship program director to Courtney Harris (harricou@musc.edu) by October 15, 2023. Virtual interviews will be scheduled upon receipt of all application materials.

Please send inquiries to:

Courtney Harris, MD
Transplant Infectious Disease Fellowship Program Director
Division of Infectious Disease
Medical University of South Carolina
135 Rutledge Ave, MSC 752
Charleston, SC 29425
harricou@musc.edu
Telephone: 507-271-6580
Fax: 830-532-0487

Back to Top

MOFFITT CANCER CENTER ^{(updated March 2023)}   

Established in 1981, Moffitt Cancer Center is Florida’s only National Cancer Institute-designated Comprehensive Cancer Center and one of only 30 leading cancer centers in the U.S. participating in the National Comprehensive Cancer Network. Moffitt is at the very forefront of cancer centers worldwide in pioneering advances like CAR T-cell therapy. 

Moffitt is offering a funded, one-year Transplant Infectious Diseases (TID) fellowship starting July 1 annually. 

Applicants should be board certified in General Internal Medicine and board eligible/board certified in Adult Infectious Diseases (minimum 2-year fellowship experience to finish prior to start of the TID fellowship).  Moffitt is the primary teaching site with rotations including microbiology, dedicated research time, exposure to robust allogeneic, autologous and immunotherapy services (i.e CAR-T), and a continuity clinic. Tampa General Hospital will serve as a site for solid organ transplant exposure via clinical rotations and regular organ meetings for kidney, heart, lung and liver transplants. Both sites are high-volume centers with access to high-quality teaching opportunities and multi-disciplinary conferences.  The TID team at Moffitt includes members who have interests in antimicrobial stewardship in transplant, ID and Pharmacy. 

Additionally, Moffitt offers a 4-week elective in adult Transplant ID/Bone Marrow Transplant ID rotations for visiting ID fellows of other programs. Fellows should be in good standing in their respective accredited programs. Formal lectures are given at minimum once a week by a member of the team. 

For more information and application, please visit our Moffitt Transplant ID Fellowship webpage or contact Mr. Martin Krämer, GME Moffitt Transplant Infectious Diseases Program Administrator at martin.kramer@moffitt.org, or 813-745-2069

Interested applicants should email a curriculum vitae, personal statement, three letters of recommendation (one from current program director), USMLEs, ECFMG (if applicable), and proof of medical school/residency. No visa sponsorship is available for this program. 

Aliyah Baluch, MD, MSc, FACP, FIDSA
Program Director, Transplant Infectious Diseases Fellowship
Moffitt Cancer Center
12902 Magnolia Drive, MCC-GMETampa, FL 33612
Telephone: (813) 745-2069
Fax: (813) 449-6537
Email: aliyah.baluch@moffitt.org

Back to Top

NATIONAL INSTITUTES OF HEALTH, NATIONAL INSTITUTES OF ALLERGY AND INFECTIOUS DISEASE in conjunction with THE JOHNS HOPKINS COMPREHENSIVE TRANSPLANT AND ONCOLOGY ID PROGRAM ^{(Updated January 2021)}

NIH/NIAID is offering a funded one-year clinical fellowship under one large transplant ID oriented expert collaborative. The fellowship spans two major transplant institutions: The National Institutes of Health Blood and Inherited Diseases Cellular Therapy Program (BID-CTP) and The Johns Hopkins Comprehensive Transplant and Oncology ID Program (TOID). This intensive clinical training program enables specialization in the field of solid organ and stem cell transplantation to collaborate across institutes. This Blood and Inherited Diseases- Cellular Therapy Program encompasses all stem cell transplants within the NIH Clinical Center encompassing The National Cancer Institute (NCI), the National Institute of Allergy and Infectious Diseases (NIAID), the National Human Genome Research Institute and the National Heart, Lung and Blood Institute (NHLBI). Stem cell transplantation and CAR-T therapy are used in a variety of malignant and non-malignant hematopoietic disorders including leukemias and aplastic anemia. Additionally, there will be a wide clinical training exposure to transplant in a variety of primary immunodeficiencies such as Chronic Granulomatous Disease GATA2 deficiency, Hyper IgE, DOCK 8 as well as other primary immunodeficiencies. The Johns Hopkins Comprehensive Transplant and Oncology ID (TOID) Program and Johns Hopkins has a comprehensive, cutting-edge transplant program encompassing a broad range of solid organ and HSCT transplants, including composite tissue allotransplantation, haploidentical HSCT, and HLA/ABO-incompatible kidney transplantation.

The fellow will spend 4-5 months at both institutions during this intensive clinical year. There is a particular focus on:

• The interaction between immune function, infection assessment pre- and post-transplantation.
• Management and prevention of infection pre-transplant.
• Primary and secondary prevention of viral and fungal infections throughout transplant.
• Multidisciplinary approach to transplant in patients and families with immune deficiency.
• Understanding the molecular techniques utilized to diagnose infection in the setting of transplantation.
• Research protocols that utilize immune modulation in the setting of transplant and subsequent development of infection.

Applicants should be current or graduate fellows in good standing in an ACGME-accredited Infectious Disease Fellowship Program. All applicants must be board eligible or board certified in Infectious Diseases as well as board certified in Internal Medicine or Medicine and Pediatric board certified. This fellowship follows the academic year with a start date of July 1. Please forward a curriculum vitae and statement of interest and two letters of recommendation to:

Christa Zerbe, M.D. M.S.
Director, Clinical Patient Services
Director, Infectious Disease Fellowship Program NIH
Laboratory of Clinical Immunology and Microbiology, NIAID
10 Center Drive
12C110, MSC 1899
Bethesda Md, 20892
Or email: zerbech@niaid.nih.gov

Back to Top

• Nationwide Children's Hospital/Ohio State University

NATIONWIDE CHILDREN'S HOSPITAL/OHIO STATRE UNIVERSITY ^{(Added October 2023)}

Intrigued by infections in transplant recipients? Considering a career in pediatric transplant infectious diseases? If so, apply to the Host Defense Fellowship at Nationwide Children's - applications accepted through March 2024. 

The one-year Infectious Disease Host Defense Fellowship provides training and expertise in the comprehensive management of infections in immunocompromised children, including:

• Hematopoietic Cell Transplantation (HCT) recipients
• Solid Organ Transplantation (SOT) recipients
• Children with malignancies
• Children with primary immunodeficiencies
• Children with autoinflammatory or autoimmune diseases receiving immunosuppressive therapies

Check out the link to learn more: Host Defense Fellowship.

Sanya Thomas, MD
Assistant Professor of Pediatrics
Pediatric Infectious Diseases, Host Defense Program
sanya.thomas@nationwidechildrens.org

STANFORD UNIVERSITY ^{(Updated July 2023)}

The Division of Infectious Diseases & Geographic Medicine at Stanford University School of Medicine offers two fully funded, one-year fellowships in the expanding field of Immunocompromised Host Infectious Diseases (Transplant ID). This clinical fellowship runs from July to June each year and is one of the oldest such programs in the country. 

This experience provides rigorous specialized training in infectious diseases specific to patients undergoing solid organ transplantation (heart, lung, liver, kidney, and pancreas), hematopoietic cell transplantation, patients with hematologic malignancies, and those with innate or acquired immunodeficiencies. Stanford Hospital and Clinics has a very robust solid organ transplantation program and a large and growing comprehensive cancer center. Fellows see an incredible variety of infectious and immunologic issues in such patients on our busy transplant ID services at Stanford.  The fellowship experience is comprised of rotations on Stanford’s inpatient Transplant ID consult services, as well as the opportunity to rotate directly as part of the transplant teams, elective time for QI projects or clinical research, and a continuity Transplant ID clinic.  We have nine ID faculty members with a specific interest in immunocompromised host/transplant ID, and teaching is a top priority for all of them. There are also further opportunities to do translational and clinical research for motivated fellows who would like to stay in the program for a longer duration.

Eligible applicants would have completed at least two years of an ACGME-accredited ID fellowship program by the start of the program, and be either board certified or board eligible in infectious diseases, and board certified in internal medicine. We encourage any interested fellows to apply for this unique training opportunity. Stanford is an equal opportunity employer and welcomes applications from women and minorities. Applications are accepted on a rolling basis; for full consideration of our fellowship that will being on July 1, 2024, please submit your applications by September 1, 2023, including the following:

• A personal statement
• A current curriculum vitae
• Reference letters from the ID fellowship program director and at least two others who know the applicant well

Please email application materials by September 1 to:

Denise Fortes
Transplant ID Fellowship Coordinator
dfortes@stanford.edu

Questions can be directed to:

Dr. Aruna Subramanian
Chief, Immunocompromised Host Infectious Diseases Service
asubram2@stanford.edu

Back to Top

UNIVERSITY OF ALABAMA AT BIRMINGHAM IMMUNOCOMPROMISED/TRANSPLANT ID FELLOWSHIP POSITION ^{(Updated July 2023)}

The Division of Infectious Diseases, Department of Medicine at the University of Alabama at Birmingham is seeking candidates for a one-year clinical (non-ACGME accredited) fellowship position in Immunocompromised/Transplant Infectious Diseases.

The focus of this position is to provide advanced training in the expanding field of Immunocompromised/Transplant Infectious Diseases and will offer exposure to patients undergoing heart, lung, liver, and kidney transplantation and ventricular assist device implantation, as well as patients with hematologic malignancies and undergoing hematopoietic cell transplantation. Research opportunities in basic/translational science in the immunocompromised host, the Mycoses Study Group, undergraduate/graduate medical education, quality improvement, infection prevention/antimicrobial stewardship are available.

Successful applicants will be appointed to a full-time faculty position as Clinical Instructor, precepted by UAB Immunocompromised/Transplant ID faculty. Individuals appointed to this position are anticipated to work on the inpatient UAB Immunocompromised/Transplant ID services for approximately 7-8 months. This will include approximately 1 weekend per month of coverage as well as working over one major holiday. Additionally, there will be an opportunity to participate in 3-4 months of elective time designed to complement Immunocompromised/Transplant ID training and provide time for pursuit of scholarly activities.

QUALIFICATIONS

Basic qualifications (required at time of application)

• Must have completed at least two years of an ACGME-accredited Infectious Diseases fellowship program
• Must be board certified or board eligible in Infectious Diseases
• Must have a AL medical license or be AL license-eligible
• J1 or HIB visa or J1 waver eligible
• An M.D. or D.O. is required
• APPLICATION REQUIREMENTS

Document requirements

• Curriculum Vitae - Your most recently updated C.V.
• Cover Letter
• Statement of Research and/or Teaching

Reference requirements

• 2-3 references required

References may be contacted

FOR MORE INFORMATION:

• Anoma Nellore, MD, UAB Director Immunocompromised ID program: anellore@uabmc.edu.
• Todd McCarty, MD. UAB ID Fellowship Program Director: tmccarty@uabmc.edu

 

Back to Top

UNIVERSITY OF ALBERTA, CANADA ^{(Updated July 2020)}

The University of Alberta is pleased to offer a one-year clinical fellowship in the field of Transplant Infectious Diseases. This position is funded through the support of Alberta Health Services and supported by the Alberta Transplant Institute (http://www.albertatransplantinstitute.ualberta.ca/). The University of Alberta in Edmonton is home to a large, world-class multi-organ transplant program. There is a team of dedicated Transplant Infectious Diseases physicians engaged both in clinical care and active clinical and translational research. Eligible candidates must have completed Infectious Diseases and/or Medical Microbiology training by the start date of the Fellowship. Applications from international trainees are encouraged.

The requirements for medical education registration in Alberta can be found at: http://www.cpsa.ca/eligibility/postgraduate-training/. In addition to clinical training, the Fellow will have the opportunity to pursue clinical, translational, or basic science research in the field of Transplant Infectious Diseases. Fellows are strongly encouraged to carry out a second year of research training following the clinical fellowship.

The start of the training period is July 1, with limited flexibility around this date. The deadline for submission of applications is August 31 of the year preceding the desired start date. Remuneration is at the level of a 6th year resident (R6) as per the Professional Association of Resident Physicians of Alberta collective agreement (http://para-ab.ca/para-agreement/).

Interested applicants should email: 1) A cover letter outlining their career goals, 2) An updated curriculum vitae, and 3) At least three letters of reference to Dr. Dima Kabbani at dkabbani@ualberta.ca

Back to Top

UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE ^{(Updated October 2023)}

The University of Miami Miller School of Medicine Division of Infectious Diseases and the Miami Transplant Institute offer 2 fully funded one-year fellowship positions in Transplant Infectious Diseases (TID) each year. Applicants must have completed a two-year general Infectious Diseases fellowship prior to the start of this additional year of training.

The Miami Transplant Institute based at Jackson Memorial Hospital has 50 years of solid organ transplant experience and has been among the highest volume transplant centers in the United States. In addition, the stem cell transplant program at the Sylvester Cancer Center performs almost 200 hematopoietic stem cell transplants and over 40 CAR-T cell infusions annually. TID fellows attend transplant selection, quality, and morbidity, and mortality committee meetings. Fellows participate actively in Transplant ID journal club and case conferences.

The fellowship includes 6 months of inpatient clinical rotations covering both the solid organ and malignant hematology/stem cell transplant infectious diseases services, as well as outpatient clinical care of pre-and post-transplant patients. Fellows will also spend 2 weeks at the local organ procurement organization and have the option to elect time in the microbiology laboratories, as well as to participate in antimicrobial stewardship and infection control activities focused on immunocompromised patients.  

The Transplant Infectious Diseases fellowship also includes 6 months of research time with opportunities for mentorship in basic, translational, and clinical research with established investigators in hematology, transplant medicine, infection control, antimicrobial stewardship, tropical medicine, and infectious diseases. Active clinical research programs in both solid organ and stem cell transplant are available. 

Applications for fellowship positions in the 2024-2025 academic year will be accepted starting in April 2024. The application must include a letter of interest, updated CV, and 2 letters of recommendation on medical center letterhead. Applicants must be board eligible or board certified in Infectious Diseases by July 1, 2023.

Michele I. Morris, M.D., FACP, FIDSA, FAST
Professor of Clinical Medicine; Director, Immunocompromised Host Service
Division of Infectious Diseases, University of Miami Miller School of Medicine
Phone 305-243-4598
mmorris2@miami.edu

Back to Top

UNIVERSITY OF MINNESOTA (Updated July 2024)

Back to Top

UNIVERSITY OF NORTH CAROLINA ^{(Updated July 2023)}

The Immunocompromised Host Infectious Disease Program (ICH ID) at the University of North Carolina (UNC) at Chapel Hill has two positions each year for a 12 month (July 1-June 30) advanced training year. This fellowship combines strong clinical training in inpatient and outpatient consultative services for immunocompromised hosts combined with education and training in one of 3 tracks: 1) antimicrobial stewardship and hospital epidemiology, 2) clinical trials, or 3) quality improvement and research.

Training consists of:

1. 24 weeks of inpatient consultation with UNC ICH ID Service, which provides care for patients with solid organ (heart, lung, liver, kidney, pancreas) and hematopoietic stem cell transplant, hematological malignancy, and burn injury
2. 1 half-day per week providing outpatient ID care in either the Transplant Clinic and/or the Hematology Oncology Clinic
3. 24 weeks of service with 1) the Antimicrobial Stewardship Program and the Department of Hospital Epidemiology, 2) the ID Inpatient Studies Team, and/or 3) the Institute of Healthcare Quality Improvement to learn about additional approaches to improving care for immunocompromised patients.

Fellows will participate in selection meetings for organ and stem cell transplantation. Fellows may also choose to take part in the Anti-infective Subcommittee of the Pharmacy and Therapeutics Committee, attend workshops on stewardship practices and infection control, act as a sub-investigator for clinical trials, and/or perform quality improvement or research projects.

These positions are open to physicians who will have completed an ACGME-certified clinical infectious disease fellowship or the equivalent by the start date of the program. We review applications as they are received beginning July 1st of the year prior to the start of the fellowship. We are able to sponsor J-1 visas for applicants who are certified or obtaining certification from the ECFMG. Interested applicants may request further information or submit a letter of intent and a current curriculum vitae to anne_lachiewicz@med.unc.edu. 2-3 letters of recommendation, including one from your program director, are also requested prior to scheduling an interview.

Current medicine residents or ID fellows are also welcome to visit for a one-month clinical elective to train with the UNC Immunocompromised Host ID inpatient consult service. Please contact Marla Allen at Marla_Allen@med.unc.edu regarding opportunities for elective rotations.

I look forward to hearing from you!

Anne Lachiewicz, MD, MPH
Associate Professor of Medicine
Division of Infectious Diseases
University of North Carolina at Chapel Hill
130 Mason Farm Rd, CB#7030
Chapel Hill, NC 2799-7030
Phone: 919-966-2537
Email: anne_lachiewicz@med.unc.edu

Back to Top

UNIVERSITY OF PITTSBURGH MEDICAL CENTER (Updated August 2023)

The Division of Infectious Diseases at the University of Pittsburgh Medical Center (UPMC) invites applicants for a funded one-year specialized Transplant Infectious Diseases (TID) fellowship starting July 1 through June 30 of the following year.

UPMC is one of the largest solid organ transplant (SOT) centers in the US and includes longstanding programs in heart, lung, liver, kidney, pancreas, intestinal, and multivisceral transplantations. In addition, TID fellows will be exposed to patients with hematological malignancies (leukemia/lymphoma, autologous and allogeneic hematopoietic cell transplant recipients, and CAR-T-cell therapy recipients) at UPMC’s cancer center, which was ranked #7 nationally. The TID Fellowship curriculum includes six months of clinical SOT training and 1 month of clinical hematological malignancy training, during which the fellow will be rounding on in-patient service with a dedicated group of TID attendings and will develop expertise in managing bacterial infections (including those caused by multidrug resistant organisms, Nocardia, mycobacteria), various viral infections (including CMV, respiratory viral infections) and invasive fungal infections. The TID fellow will have an opportunity to participate in the SOT TID Clinic, providing pre-transplant evaluations and post-transplant follow up of recipients with various infectious issues immediately before and long-term after transplantation. Interested fellows may also participate in the ventricular assist device (VAD) and hematological malignancy clinics. For the remaining five months of research, our TID program offers exceptional opportunities in basic, translational, and clinical research, with a robust and successful mentorship program in place.

Candidates will need to have completed at least two years of general ID fellowship training at an ACGME-accredited Infectious Disease Fellowship Program. Foreign medical graduaes will need to be ECFMG-certified. We accept applicants on J1 visas. Applicants should submit their CV, personal statement, and 3 letters of recommendation (sent by the letter authors) to: Dr. Ghady Haidar at haidarg@upmc.edu and Ms. Sarah Glenn (fellowship coordinator) at glennse@upmc.edu.  

The University of Pittsburgh Medical Center is an Affirmative Action, Equal Opportunity Employers.

Back to Top

UNIVERSITY OF TEXAS AT HOUSTON MCGOVERN MEDICAL SCHOOL ^{(Updated July 2019)}

The Division of Infectious Diseases at the University of Texas at Houston Mc Govern Medical School offers a funded; one-year Texas Medical Board approved Transplant Infectious Diseases Fellowship. This position is open to physicians who will have completed an ACGME-certified clinical Infectious Disease fellowship or the equivalent by the start date of the program.

Our fellowship combines outpatient and inpatient clinical training in lung, liver, pancreas, kidney, heart, and HSCT transplant patients under supervision of a dedicated group of transplant infectious diseases attendings. The fellowship is conducted at Memorial Hermann Hospital, a national leader in the field of transplantation and at MD Anderson Cancer Center, the number one cancer hospital in the US. Performing a translational and or clinical research project is encouraged during this year.

For more information, please contact Ms. Sandra Warrie at Sandra.R.Warrie@uth.tmc.edu.

Applicants should submit their CV and personal statement to:

Rodrigo Hasbun, MD
Program Director
Transplantation Infectious Disease Fellowship Program
Internal Medicine/Division of Infectious Diseases
McGovern Medical School –UT Houston
6431 Fannin, MSB 2.112
Houston, Texas 77030
E-mail: Rodrigo.Hasbun@uth.tmc.edu

Back to Top

UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER ^{(Updated July 2023)}

The Department of Infectious Diseases, Infection Control and Employee Health at The University of Texas MD Anderson Cancer Center offers 1-2 year (funded) additional fellowship training in Adult Onco-Transplant Infectious Diseases to fellows graduating from ACGME accredited program in the U.S. Fellows in this program will gain expertise in the prevention and management of infections in immunocompromised and cancer patients with an emphasis on infections in patients with leukemia, lymphoma and undergoing hematopoietic stem cell transplantation. In addition, fellows rotate at Memorial Hermann Hospital Texas Medical Center for exposure to solid organ transplant patients. Fellows will have protected time to pursue clinical research and educational activities.

In addition to the 1-2 year program, the Gerald P. Bodey visiting fellows program offers a one month clinical elective rotation for fellows in ACGME-accredited Infectious Diseases Fellowship Programs in the U.S. who would like to gain in-depth clinical experience in the diagnosis, prevention and treatment of infections in patients undergoing hematopoietic stem cell transplantation. To date >150 fellows have rotated at MDACC as part of this program.

For more information or to apply for either one of the opportunities, please send a letter of interest, a recent curriculum vitae, 2 letters of recommendation and a personal statement to Dr. Pablo Okhuysen at pcokhuysen@mdanderson.org. 

Please send inquiries to:

Pablo C. Okhuysen, MD, FACP, FIDSA
Program Director
Onco-Transplant Infectious Diseases Program
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd., Unit 1460
Houston, Texas, 77030

Telephone (713) 745-8413
Fax: (713) 745-6839
pcokhuysen@mdanderson.org

Link to the MD Anderson Cancer Center Infectious Diseases Combined Fellowship Programs Page.

Back to Top

UT SOUTHWESTERN UNIVERSITY MEDICAL CENTER (New May 2023)

The UT Southwestern University Medical Center Transplant Infectious Diseases fellowship is a fully funded, 1-year sub-specialty training program. Fellows will develop expertise in the care of patients in pre- and post-transplant settings for renal, liver, heart, lung, and multi-organ transplantation. Additionally, fellows will learn to manage infections in patients with hematologic malignancies, including hematopoietic stem cell transplant and CAR-T recipients.

UT Southwestern Medical Center is the largest transplant center in North Texas, serving a diverse community, with a catchment area extending throughout Texas and neighboring states. The Transplant Infectious Diseases group is comprised of 7 faculty members with clinical and research expertise spanning a broad range of areas within Immunocompromised Host Infectious Diseases.

The Transplant Infectious Diseases curriculum emphasizes the multi-disciplinary care of immunocompromised patient populations. Fellows will spend 6 months on the inpatient Transplant ID consult service as well as time embedded with our solid organ transplant medicine and surgical teams as well as Hematology/Oncology services. Twelve-weeks of elective time are available for elective clinical rotation or longitudinal research projects. Our faculty are internationally recognized for their work on donor derived infections, norovirus, and multidrug resistant organisms. Opportunities for research include access to the UT Southwestern Transplant Infectious Diseases Database as well as a genomic database of MDR organisms.

In addition to clinical service, and research opportunities, a formal curriculum including weekly Transplant ID lectures and journal clubs ensures exposure to all core areas of Transplant ID and Transplant Medicine. Fellows may elect to participate in donor-call with faculty to build expertise in critical aspects of organ selection.

All applicants should have finished 2 years of General Infectious Diseases training though consideration will be made for exceptional candidates without this qualification. International medical graduates are welcome to apply, and support is available for J1 visas. Applicants should send a brief statement of interest, 3 letters of recommendation and a CV by October 1st of the year prior to intended start date to:

Ricardo M. La Hoz, MD, FACP, FAST, FIDSA
Director, Solid Organ Transplant Infectious Diseases
Program Director, Transplant Infectious Diseases Fellowship
Associate Professor of Internal Medicine
UT Southwestern Medical Center
Email: Ricardo.LaHoz@UTSouthwestern.edu

And

Christian Larsen, MD
Associate Program Director, Transplant Infectious Diseases Fellowship
Assistant Professor of Internal Medicine
UT Southwestern Medical Center 
Email: Christian.Larsen@UTSouthwestern.edu

Back to Top

VANDERBILT UNIVERSITY MEDICAL CENTER ^{(Updated June 2024)}

Vanderbilt University Medical Center (VUMC), Department of Medicine, Division of Infectious Diseases welcomes applicants for a 12 month, fully funded Transplant Infectious Diseases (TID) Fellowship. VUMC performs over 700 adult SOT/year, over 350 HSCT/year, as well as extensive programs for CAR-T and induction chemotherapy for hematologic malignancy. Patients seen by the Transplant ID consulting service include solid-organ transplant recipients (heart, lung, liver, kidney, pancreas, and dual-organ), hematopoietic stem-cell transplant recipients (allogenic, autologous, and CAR-T), as well as patients receiving therapy for hematologic malignancies. Fellows will spend 6 months on the inpatient TID consult service in 1:1 interaction with a core of 6 dedicated TID faculty members.

Deadline July 31, 2024.

Prerequisites:

• Completion of an ACGME approved Infectious Diseases Fellowship Program
• The Department of Medicine is unable to sponsor H1B visas for this Fellowship position.

Clinical Duties:

• 6 months on the inpatient TID service (Solid organ and hematologic malignancy)
• Attend SOT and HSCT selection committee meetings
• Complete a research project (research opportunities can be tailored to the interest of the TID Fellow)
• 6 case presentations to the ID division, 1 journal club
• Additional opportunities include attendance at the AST Fellows Symposium in Dallas, participation in Vanderbilt’s “Distinction in Transplant Administration” course, and presenting at multi-disciplinary educational conferences for non-ID trainees
• 1-2 half days of TID clinic per week

Application Materials:

1. Curriculum vitae
2. Cover letter
3. Three letters of recommendation, one must be from the Division Director of Infectious Diseases

Please send to:

Nora M. Gilgallon-Keele
Infectious Diseases Fellowship Program Manager
Vanderbilt University Medical Center, Division of Infectious Diseases
1161 21st Avenue South, #MCN A-2206, Nashville, TN 37232
Ph - (615)343-4578  Fax - (615)343-6160 
nora.m.gilgallon-keele@vumc.org

Please direct any questions to:

Kevin C. Dee, MD
Program Director, Transplant Infectious Disease Fellowship
kevin.c.dee@vumc.org

Back to Top

ADDITIONAL OPPORTUNITIES:

EMORY UNIVERSITY

Clinical rotation organized through Graduate Medical Education for Adult or Pediatric Infectious Diseases Fellows, Adult Critical Care Fellows, and Medicine house staff. It is an elective clinical rotation on a standard hospital consultative training service with the addition of one morning per week in the Transplant Infectious Diseases Clinic and attendance of Transplant Grand Round, ID research seminar, and ID Case of the Week Conference.

Contact:

G. Marshall Lyon
Director, Transplant Infectious Diseases Section
(404) 712-2051

Or

Aneesh K. Mehta
Assistant Director, Transplant Infectious Diseases Section
aneesh.mehta@emory.edu
(404) 727-8435

Division of Infectious Diseases
Emory University School of Medicine
101 Woodruff Circle, WMB 2101
Atlanta, GA 30033

Back to Top

ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI

The Transplant Infectious Diseases Program at The Mount Sinai Hospital offers infectious diseases fellows who are currently enrolled in ACGME-accredited programs a four-week clinical rotation. Visiting fellows will work as part of the Solid Organ Transplant ID Consult Service and/or the BMT/Oncology ID Consult Service with exposure to a wide variety of infections in kidney, liver, intestine, pancreas, and heart transplant candidates and recipients and/or stem cell transplant recipients. As part of their rotation, fellows will be provided with a curriculum in transplant infectious diseases and will participate in didactic sessions, weekly microbiology rounds, case conferences, and journal club. The program currently provides training to infectious diseases fellows from other NYC-area programs that do not offer an experience in transplant infectious diseases. However, infectious diseases fellows from all accredited programs in the United States and Canada are eligible for application.

Contact: Sarah Taimur, MD at sarah.taimur@mssm.edu.

Back to Top

OCHSNER MEDICAL CENTER

The Department of Infectious Diseases at Ochsner Medical Center in New Orleans, Louisiana, is offering a one-month clinical rotation with the Transplant and Immunocompromised Host consultation service. Services are provided for solid-organ transplant recipients (liver, kidney and kidney-pancreas, heart, and lung), as well as hematopoietic stem cell transplant recipients and patients with hematologic malignancies. Though the rotation primarily focuses on the inpatient consultation service, there are also opportunities to participate in multidisciplinary donor and candidate evaluation processes. This month also includes weekly participation in clinical microbiology rounds, ID case conference, New Orleans Citywide conference, and involvement in medical student and house staff education. The goal of this rotation is to offer diverse clinical exposure and unique educational opportunities specific to these populations and is available to ID fellows who have completed their first year of fellowship in an ACGME-accredited training program. Ochsner Medical Center is the nation's largest Liver Transplant program by volume, performing 210 transplants in 2018, and 148 kidney transplants in 2018 with over 200 expected in 2019. In addition to the unique patient care experience at Ochsner Medical Center, the city of New Orleans offers world renowned cultural attractions.

Contact:

Jonathan Hand, MD at jonathan.hand@ochsner.org
(504) 842-1191
1514 Jefferson Hwy.
New Orleans, LA 70121

Back to Top